Stock SVS SVAS BIOSANA S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Svas Biosana S.p.A. Stock

Equities

SVS

IT0005469264

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-05-10 am EDT 		5-day change 1st Jan Change
8.05 EUR 0.00% Intraday chart for Svas Biosana S.p.A. -0.62% +0.62%
May. 10 Mib rises above 34,500; Iveco leads rises AN
May. 09 Svas Biosana increases revenues by single digits in first quarter AN
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 124M 133M Sales 2025 * 130M 139M Capitalization 43.46M 46.8M
Net income 2024 * 6M 6.46M Net income 2025 * 7M 7.54M EV / Sales 2024 * 0.57 x
Net Debt 2024 * 27.5M 29.62M Net Debt 2025 * 25.4M 27.35M EV / Sales 2025 * 0.53 x
P/E ratio 2024 *
7.12 x
P/E ratio 2025 *
6.29 x
Employees 323
Yield 2024 *
-
Yield 2025 *
-
Free-Float 31.42%
More Fundamentals * Assessed data

Chart Svas Biosana S.p.A.

Dynamic Chart

Latest news about Svas Biosana S.p.A.

Mib rises above 34,500; Iveco leads rises AN
Svas Biosana increases revenues by single digits in first quarter AN
Svas Biosana S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Svas Biosana increases profit in 2023; ex-dividend proposed AN
Mib bullish; Leonardo on top AN
Milan rises; Israel will not respond to Tehran AN
Mib bullish; Larry Fink sees only two Fed cuts AN
Svas Biosana takes over 1,800 treasury shares for more than EUR15,000 AN
Svas Biosana buys more than 2,000 of its own ordinary shares AN
Svas Biosana buys back own shares for more than EUR34,000 AN
Svas Biosana buys back own shares for nearly EUR30,000 AN
ITALY GROWTH WINNERS & LOSERS: Good Rocket Sharing; down Svas Biosana AN
Svas Biosana, double-digit revenue growth in 2023 AN
Leonardo leads rises but Mib opens flat AN
Futures on "sell" side; UK inflation stable AN
More news

Press releases Svas Biosana S.p.A.

Svas Biosana S p A : The Board of Directors of SVAS Biosana approves the short-form consolidated half-yearly financial statements as at 30 june 2023 PU
Svas Biosana S p A : The Board of Directors of SVAS Biosana examines the consolidated turnover as at 30 june 2023 PU
Svas Biosana S p A : Beginning of the second exercise period for SVAS Biosana PU
Svas Biosana S p A : Financial statements as at and for the year ended 31 December 2022 approved PU
Svas Biosana S p A : Approval of consolidated revenues Q1 2023 PU
More press releases

News in other languages on Svas Biosana S.p.A.

Mib sale oltre 34.500; Iveco guida i rialzi
Svas Biosana aumenta i ricavi a una cifra nel primo trimestre
Svas Biosana S p A : Il CDA di SVAS Biosana esamina i ricavi consolidati al 31 Marzo 2024
Svas Biosana S p A : Bilancio d'esercizio FY 2023
Svas Biosana S p A : Pubblicazione assemblea e messa a disposizione dei documenti
More news

Quotes and Performance

1 week-0.62%
Current month-0.62%
1 month-1.23%
3 months-0.12%
6 months+15.00%
Current year+0.62%
More quotes

Highs and lows

1 week
8.00
Extreme 8
8.35
1 month
7.80
Extreme 7.8
8.55
Current year
7.20
Extreme 7.2
8.60
1 year
6.90
Extreme 6.9
8.66
3 years
6.90
Extreme 6.9
16.30
5 years
6.90
Extreme 6.9
16.30
10 years
6.90
Extreme 6.9
16.30
More quotes

Managers and Directors - Svas Biosana S.p.A.

Managers TitleAgeSince
Umberto Perillo CEO
 Chief Executive Officer 63 12-03-27
Andrea Efficace DFI
 Director of Finance/CFO - -
Members of the board TitleAgeSince
Antonio Finocchi Ghersi BRD
 Director/Board Member 61 15-06-29
Umberto Perillo CEO
 Chief Executive Officer 63 12-03-27
Filippo Maraniello CHM
 Chairman 74 12-03-27
More insiders

Quotes

Date Price Change Volume
24-05-10 8.05 0.00% 4,286
24-05-09 8.05 -0.62% 400
24-05-08 8.1 0.00% 0
24-05-07 8.1 0.00% 22,104
24-05-06 8.1 0.00% 851

Real-time Borsa Italiana, May 10, 2024 at 11:44 am EDT

More quotes

Company Profile

Svas Biosana Srl is an Italy-based company, which manufactures and markets medical devices and pharmaceutical products. The Company consists of four divisions namely: Farmex division, manufactures range of gauze and cotton made products; Medical division, provides suction line, infusion line, and custom packs; Svas division, provides own brand products, specialities, galenic solutions and disposables; and Harvest division, provides electromedical equipments, after-sales technical services. The Company is the subsidiary of Svas group. Test Data.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-05-14 - Shareholders Meeting
More about the company

Income Statement Evolution

More financial data

Ratings for Svas Biosana S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
8.05 EUR
Average target price
14.2 EUR
Spread / Average Target
+76.40%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SVAS BIOSANA S.P.A. Stock Svas Biosana S.p.A.
+0.62% 46.8M
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.84% 182B
MEDTRONIC PLC Stock Medtronic plc
+0.56% 110B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.35% 68.11B
DEXCOM, INC. Stock DexCom, Inc.
+2.39% 50.53B
CENCORA, INC. Stock Cencora, Inc.
+9.36% 44.8B
HOYA CORPORATION Stock Hoya Corporation
+2.70% 40.7B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.43% 26.53B
TERUMO CORPORATION Stock Terumo Corporation
+13.67% 25.02B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-0.32% 24.96B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. SVS Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW